Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118301322 | 11830132 | 2 | F | 20160704 | 20151214 | 20160705 | EXP | TW-ROCHE-1675710 | ROCHE | , HUANG C, HUANG C, HSIEH M, HUANG J, DAI C, CHUANG W AND YU M. PERSONALIZED THERAPY OF CHRONIC HEPATITIS C AND B DUALLY INFECTED PATIENTS WITH PEGYLATED INTERFERON PLUS RIBAVIRIN A RANDOMIZED STUDY. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY 2015;13(7):1384-1384. | 0.00 | Y | 0.00000 | 20160706 | MD | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118301322 | 11830132 | 1 | PS | RIBAVIRIN. | RIBAVIRIN | 1 | Unknown | U | 21511 | TABLET | |||||||||
| 118301322 | 11830132 | 2 | SS | RIBAVIRIN. | RIBAVIRIN | 1 | U | 21511 | |||||||||||
| 118301322 | 11830132 | 3 | SS | Peg-Interferon Alfa 2a | PEGINTERFERON ALFA-2A | 1 | Unknown | U | 103964 | SOLUTION FOR INJECTION | |||||||||
| 118301322 | 11830132 | 4 | SS | Peg-Interferon Alfa 2a | PEGINTERFERON ALFA-2A | 1 | U | 103964 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118301322 | 11830132 | 1 | Hepatitis C |
| 118301322 | 11830132 | 2 | Hepatitis B |
| 118301322 | 11830132 | 3 | Hepatitis C |
| 118301322 | 11830132 | 4 | Hepatitis B |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 118301322 | 11830132 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118301322 | 11830132 | Alopecia | |
| 118301322 | 11830132 | Anaemia | |
| 118301322 | 11830132 | Anxiety | |
| 118301322 | 11830132 | Chills | |
| 118301322 | 11830132 | Decreased appetite | |
| 118301322 | 11830132 | Depression | |
| 118301322 | 11830132 | Diarrhoea | |
| 118301322 | 11830132 | Headache | |
| 118301322 | 11830132 | Injection site reaction | |
| 118301322 | 11830132 | Insomnia | |
| 118301322 | 11830132 | Leukopenia | |
| 118301322 | 11830132 | Myalgia | |
| 118301322 | 11830132 | Nausea | |
| 118301322 | 11830132 | Pyrexia | |
| 118301322 | 11830132 | Rash | |
| 118301322 | 11830132 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |